cdmo.directory
← Compare landing

ADViRNA vs TriLink BioTechnologies

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryADViRNATriLink BioTechnologies
SummaryADViRNA provides oligonucleotide design, synthesis, and screening services with proprietary chemical modifications and conjugation technologies for therapeutic siRNA and ASO development.TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
Services
  • Translational Research
  • Bioconjugation Services
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • API Synthesis & Manufacturing
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
Modalities
  • Oligonucleotide
  • Oligonucleotide
  • mRNA
Development capabilities
  • Analytical method development
  • Analytical method development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Substance (DS)
  • Expression: Cell-Free
  • Max chemical: Pilot (10 kg – 100 kg)
LocationsData not yet provided.
  • Headquarters
CertificationsData not yet provided.Data not yet provided.

Find similar companies

ADViRNA alternatives · TriLink BioTechnologies alternatives

Markdown mirror: /compare/advirna/trilinkbiotech.md